Assignee profile:

Immunome, Inc.

City:

Bothell, Washington

Country:

United States

Published Applications:

11

Last publication date:

2024-12-26

Patent Grants:

10

Last grant date:

2025-04-08

Top Inventors for applications by Immunome, Inc.

These are the the leading inventors for applications assigned to Immunome, Inc.:

Recent patent applications by Immunome, Inc.

Immunome, Inc. based in Bothell, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2024-12-26 ✅ Patent 12,268,750 granted on 2025-04-08
US20240424124A1
Human necessities

Immunoconjugates and methods

#2 | 2024-12-26 ✅ Patent 12,285,492 granted on 2025-04-29
US20240424123A1
Human necessities

Immunoconjugates and methods

#3 | 2024-12-26 ✅ Patent 12,280,121 granted on 2025-04-22
US20240424121A1
Human necessities

Immunoconjugates and methods

#4 | 2024-12-12 ✅ Patent 12,274,754 granted on 2025-04-15
US20240408224A1
Human necessities

Immunoconjugates and methods

#5 | 2024-09-26
US20240316062A1
Human necessities

COMBINATION OF IMMUNOTHERAPEUTICS AND BISFLUOROALKYL-1,4-BENZODIAZEPINONE COMPOUNDS FOR TREATING CANCER

#6 | 2024-03-07 ✅ Patent 12,186,403 granted on 2025-01-07
US20240075153A1
Human necessities

Immunoconjugates and methods

#7 | 2023-04-20 ✅ Patent 12,545,716 granted on 2026-02-10
US20230123041A1
Human necessities

IMMUNOCONJUGATES AND METHODS

#8 | 2023-04-06 ✅ Patent 12,503,449 granted on 2025-12-23
US20230108536A1
Chemistry; metallurgy

METHODS OF PREPARING CHIRAL BENZODIAZEPINONE DERIVATIVES

#9 | 2022-09-29 ✅ Patent 12,162,945 granted on 2024-12-10
US20220306752A1
Chemistry; metallurgy

EPHA2 antibodies

#10 | 2021-02-11 ✅ Patent 12,281,085 granted on 2025-04-22
US20210040050A1
Chemistry; metallurgy

Bisfluoroalkyl-1,4-benzodiazepinone compounds and methods of use thereof

#11 | 2020-01-23 ✅ Patent 12,233,072 granted on 2025-02-25
US20200022990A1
Human necessities

Compositions comprising bisfluoroalkyl-1,4-benzodiazepinone compounds for treating Adenoid Cystic Carcinoma

Also check out Immunome, Inc.'s (Bothell, United States) applicant profile with 16 patent applications submitted.

AssigneeID:

625452 ⎘